Proactive Investors - Run By Investors For Investors

Maricann to rename itself as Wayland Group as it looks to widen its reach in cannabis

Maricann’s renaming to Wayland Group comes amid the widening of its outreach efforts for both its medical and non-medical cannabis brands
cultivation of medical marijuana
Maricann will call itself Wayland Group and trade under the ticker symbol WAYL starting tomorrow

The Canadian medical marijuana group Maricann Group Inc (CSE:MARI, OTCQB:MRRCF) has unveiled plans to change its name to Wayland Group Corp and to begin trading under the ticker symbol WAYL starting tomorrow.

Maricann’s renaming to Wayland Group comes as part of its global expansion and the widening of its outreach efforts for both its medical and non-medical cannabis brands.

“The new name reflects the more expansive portfolio that we’ve built and the direction that we’re heading as a global cannabis company,” said CEO Ben Ward.

Headquartered in Burlington, Ontario and Munich, Germany, Maricann distributes marijuana for medical purposes, offering a variety of oil and flower products.

It has production facilities in Langton, Ontario, where it operates a medicinal cannabis cultivation, extraction and distribution business under a license from the Government of Canada. It also maintains production operations in Dresden, Germany and Regensdorf, Switzerland.

Maricann’s proposed name change to Wayland is subject to the approval of its shareholders who are expected to vote on the proposal at a meeting later this year.

Maricann shares slipped 0.44% to C$2.24 in Monday’s afternoon session.

View full WAYL profile View Profile

Wayland Group Inc Timeline

Related Articles

Scientist at work
May 28 2019
CaPre, a potent form of Omega-3, has been shown to reduce triglycerides, but also lower 'bad cholesterol' levels, and raise 'good' ones
April 17 2019
Driving growth was Lojuxta, used to treat a rare and life-threatening disorder that causes abnormally high levels of bad cholesterol. Its sales grew to €13.6mln, up 14.2% year-on-year
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use